Notice of Intent To Grant an Exclusive License, 12650 [2012-4885]
Download as PDF
<![CDATA[
12650
Federal Register / Vol. 77, No. 41 / Thursday, March 1, 2012 / Notices
your community that would be
appropriate for this program and would
meet the standards required by Life
Safety Code and 38 CFR 61.1—61.82.
Application for Federal Assistance
(SF 424)—Applicants for Funding
Priority 1—in block 15a, Federal;
identify the total amount of per diem
funding your agency is requesting for
operation under the entire grant award
period of this NOFA (this number may
not exceed $48,000 per bed over the
entire grant period or $1.2 million total).
Applicants should be careful to
complete the proper application
package. Submission of an incorrect or
incomplete application package will
result in the application being rejected
at threshold. Application packages must
include all required forms and
certifications. Selections will be made
based on criteria described in the
application, Final Rule, and NOFA.
Applicants who are conditionally
selected will be notified of any
additional information needed to
confirm or clarify information provided
in the application. Applicants will then
be notified of the deadline to submit
such information. If an applicant is
unable to meet any conditions for grant
award within the specified time frame,
VA reserves the right to not award funds
and to use the funds available for other
grant and per diem applicants.
Dated: February 16, 2012.
John R. Gingrich,
Chief of Staff, Department of Veterans Affairs.
[FR Doc. 2012–4880 Filed 2–29–12; 8:45 am]
mstockstill on DSK4VPTVN1PROD with NOTICES
BILLING CODE 8320–01–P
VerDate Mar<15>2010
17:25 Feb 29, 2012
Jkt 226001
DEPARTMENT OF VETERANS
AFFAIRS
Docket Management System at https://
www.regulations.gov.
Notice of Intent To Grant an Exclusive
License
FOR FURTHER INFORMATION CONTACT:
Department of Veterans Affairs,
Office of Research and Development.
ACTION: Notice of intent.
AGENCY:
Notice is hereby given that
the Department of Veterans Affairs,
Office of Research and Development,
intends to grant to Somahlution, Inc.,
3401 Fiechtner Drive, Fargo, North
Dakota 58103, USA, an exclusive
license to practice the following: U.S.
Patent No. 7,981,596 (Tissue
preservation with a salt solution
isotonic with interstitial fluid) issued
July 19, 2011.
DATES: Comments must be received
March 16, 2012.
ADDRESSES: Written comments may be
submitted through www.regulations.gov;
by mail or hand-delivery to the Director,
Regulations Management (02REG),
Department of Veterans Affairs, 810
Vermont Avenue NW., Room 1068,
Washington, DC 20420; or by fax to
(202) 273–9026. Copies of comments
received will be available for public
inspection in the Office of Regulation
Policy and Management, Room 1063B,
between the hours of 8 a.m. and 4:30
p.m., Monday through Friday (except
holidays). Call (202) 461–4902 for an
appointment (This is not a toll-free
number). In addition, during the
comment period, comments may be
viewed online through the Federal
SUMMARY:
PO 00000
Frm 00098
Fmt 4703
Sfmt 9990
Amy E., Centanni, Director of
Technology Transfer, Office of Research
and Development (10P9TT), Department
of Veterans Affairs, 810 Vermont
Avenue NW., Washington, DC 20420,
(202) 443–5640 (This is not a toll-free
number). Copies of the published patent
applications may be obtained from the
U.S. Patent and Trademark Office at
www.uspto.gov.
It is in the
public interest to so license these
inventions, as Somahlution, Inc.,
submitted a complete and sufficient
application for a license. The
prospective exclusive license will be
royalty-bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless,
within 15 days from the date of this
published Notice, the Department of
Veterans Affairs Office of Research and
Development receives written evidence
and argument which establishes that the
grant of the license would not be
consistent with the requirements of 35
U.S.C. 209 and 37 CFR 404.7.
SUPPLEMENTARY INFORMATION:
Dated: February 23, 2012.
John R. Gingrich,
Chief of Staff, Department of Veterans Affairs.
[FR Doc. 2012–4885 Filed 2–29–12; 8:45 am]
BILLING CODE 8320–01–P
E:\FR\FM\01MRN1.SGM
01MRN1
]]>Agencies
[Federal Register Volume 77, Number 41 (Thursday, March 1, 2012)]
[Notices]
[Page 12650]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-4885]
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Notice of Intent To Grant an Exclusive License
AGENCY: Department of Veterans Affairs, Office of Research and
Development.
ACTION: Notice of intent.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Department of Veterans
Affairs, Office of Research and Development, intends to grant to
Somahlution, Inc., 3401 Fiechtner Drive, Fargo, North Dakota 58103,
USA, an exclusive license to practice the following: U.S. Patent No.
7,981,596 (Tissue preservation with a salt solution isotonic with
interstitial fluid) issued July 19, 2011.
DATES: Comments must be received March 16, 2012.
ADDRESSES: Written comments may be submitted through
www.regulations.gov; by mail or hand-delivery to the Director,
Regulations Management (02REG), Department of Veterans Affairs, 810
Vermont Avenue NW., Room 1068, Washington, DC 20420; or by fax to (202)
273-9026. Copies of comments received will be available for public
inspection in the Office of Regulation Policy and Management, Room
1063B, between the hours of 8 a.m. and 4:30 p.m., Monday through Friday
(except holidays). Call (202) 461-4902 for an appointment (This is not
a toll-free number). In addition, during the comment period, comments
may be viewed online through the Federal Docket Management System at
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Amy E., Centanni, Director of
Technology Transfer, Office of Research and Development (10P9TT),
Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC
20420, (202) 443-5640 (This is not a toll-free number). Copies of the
published patent applications may be obtained from the U.S. Patent and
Trademark Office at www.uspto.gov.
SUPPLEMENTARY INFORMATION: It is in the public interest to so license
these inventions, as Somahlution, Inc., submitted a complete and
sufficient application for a license. The prospective exclusive license
will be royalty-bearing and will comply with the terms and conditions
of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license
may be granted unless, within 15 days from the date of this published
Notice, the Department of Veterans Affairs Office of Research and
Development receives written evidence and argument which establishes
that the grant of the license would not be consistent with the
requirements of 35 U.S.C. 209 and 37 CFR 404.7.
Dated: February 23, 2012.
John R. Gingrich,
Chief of Staff, Department of Veterans Affairs.
[FR Doc. 2012-4885 Filed 2-29-12; 8:45 am]
BILLING CODE 8320-01-P
